Dr. Amedei Amedeo

Dr. Amedei Amedeo

Researcher - Laboratory Chief

University of Florence
Viale pieraccini, 06, Florence, Italy, 50134

plus Speciality

IMMUNOLOGY

Biography:

Name: Amedeo Amedei
Office address: Azienda Ospedaliera Universitaria Careggi
Department of Internal Medicine
Viale  Pieraccini 6, 50134 Firenze (Firenze, Italy)
Education:
1998: Diploma of Biologist Qualification  (University of Florence, Firenze-Italy)
1996: University Degree in Biological Science (first class honours), University of Florence, Firenze-Italy; Thesis “Helicobacter pylori infection: model of  Th1 immune response”
1990: School Leaving Certificate (awarded after five years of Liceo specializing in classical studies)

Academic positions:

From 2005: Immunology Researcher in Department  of Internal Medicine (University of Florence)
2004: Indentured Researcher in Department  of Internal Medicine; Project “Study of  specific immune response in gastric cancer”
2003: Winner of Doctorate School of Experimental and Clinical Medicine
1999-2002: Fellowship holder “Cellular and molecular mechanisms in the regulation of chronic inflammation”   
1998-1999: Contractor of Nurex Company “Development and production of reagents for monitoring immune sheep”
1997-1999: Scholarship holder of Fondazione Anna Villa Rusconi “Role of Th1/Th2 lymphocytes in the pathogenesis of Graft Versus Host”
1996-1997: Scholarship holder “Identification of specific markers of disease activity in Graft Versus Host

Research interests:

Role of immune response versus Helicobacter pylori on pathogenesis diseases correlate with human bacterium infection: ulcer-gastritis, gastric cancer, MALT-lymphoma.

Physopatology of Primitive and Secondary Immunodeficiencies.

Analysis of T specific lymphocytes versus Mycobacterium Tuberculosis peptides.

Infectious agents and specific immune T response on the genesis of atherosclerotic plaques.

Correlation between bacteria and autoimmune diseases (molecular mimicry).

Immune-Adjuvant effects of microorganism elements.

Analysis of new proteins that modulate mRNA of BCL2 gene.

Role of hERG1 K+ channels in the tumorogenesis

Characterization of immune T response specific to cancer antigens in patients with digestive system cancers

What I think of the idea behind WebmedCentral and WebmedCentral plus:

It's a good andinnovative idea